317 - Real-World Effectiveness of Dalbavancin for Invasive Gram-Positive Bacterial Infections

Friday, October 18, 2024

12:20 PM – 12:25 PM US PT

Location: Halls JK - Arena 1

Rapid Fire Presenter(s)

Jake Crocker, PharmD

Clinical Pharmacist Specialist - Infectious Diseases
Prisma Health Upstate
Columbia, SC, United States

Co-Author(s)

Caroline Derrick, PharmD (she/her/hers)

Infectious Diseases Ambulatory Pharmacy Supervisor
University of South Carolina School of Medicine
Columbia, South Carolina, United States
JJ

Julie Ann Justo, PharmD, MS, FIDSA, BCPS

Clinical Pharmacist Lead - Infectious Diseases
Dartmouth Hitchcock Medical Center
East Thetford, Vermont, United States
P. Brandon Bookstaver, PharmD

Associate Professor & Director of Residency and Fellowship Training
Prisma Health Richland - University of South Carolina
Columbia, South Carolina, United States
IY

Ismaeel Yunusa, PharmD, PhD

University of South Carolina College of Pharmacy
Columbia, South Carolina, United States
Bruce M. Jones, Pharm.D., FIDSA, BCPS

Infectious Diseases Clinical Pharmacy Specialist
St. Joseph's/Candler Health System
Savannah, GA, United States
Bryan White, PharmD, FIDSA

Infectious Diseases Clinical Pharmacist and PGY-2 ID Pharmacy Residency Program Director
University of Oklahoma Medical Center
Joseph Sassine, MD

Assistant Professor of Medicine
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
MB

Madeline Belk, PharmD

Infectious Diseases Clinical Pharmacy Specialist
Huntsville Hospital
Huntsville, Alabama, United States
Morgan Pizzuti, PharmD

Infectious Diseases Transitions of Care Pharmacist
Prisma Health Richland - University of South Carolina
Columbia, South Carolina, United States

Disclosure(s):

R Jake Crocker, PharmD: No financial relationships to disclose

Julie Ann Justo, PharmD, MS, FIDSA, BCPS: Shionogi: Advisor/Consultant

P. Brandon Bookstaver, PharmD: No financial relationships to disclose

Ismaeel Yunusa, PharmD, PhD: No financial relationships to disclose

Bruce M. Jones, Pharm.D., FIDSA, BCPS: AbbVie: Advisor/Consultant, Honoraria; Ferring: Honoraria; Innoviva: Honoraria; Paratek: Honoraria

Bryan White, PharmD, FIDSA: Melinta Therapuetics: Advisor/Consultant, Honoraria; Shionogi: Grant/Research Support

Joseph Sassine, MD: Ansun BioPharma: Grant/Research Support (); Cidara Therapeutics: Grant/Research Support (); Community Infusion Solutions: Grant/Research Support (); F2G: Grant/Research Support (); Shionogi: Grant/Research Support ()

Madeline Belk, PharmD: No financial relationships to disclose